Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Products
Texas Center for Proton Therapy Selects RayStation for Treatment Planning
Tuesday, July 07, 2015
With plans to open in late 2015, the next-generation proton center will use RayStation® exclusively for all patient planning.
Planmed Launches the New Planmed Clarity™ 3D System
Friday, July 03, 2015
Improved mammography diagnostics with Digital Breast Tomosynthesis.
Exiqon Launches ExiLERATE LNA™ qPCR Product Portfolio
Thursday, July 02, 2015
Exiqon A/S has announced the launch of the ExiLERATE LNA™ qPCR product portfolio for real-time PCR analysis of mRNAs and lncRNAs.
Validive® at the MASCC/ISOO International Symposium
Wednesday, July 01, 2015
Oral presentation of Phase II trial results and meeting with its International Advisory Board.
Biocartis’ KRAS Mutation Test Receives CE-IVD Marking
Wednesday, June 24, 2015
Biocartis’ Idylla™ KRAS Mutation Test is the first fully automated IVD KRAS Test to match novel guidelines - capable of detecting an extended panel of 21 KRAS mutations with high sensitivity.
Single-Cell Technologies Advance the Value of Genomics
Wednesday, June 24, 2015
These new technologies enable the advancement of nucleic acid research methods and open up new areas of biological enquiry for the Institute and wider science community.
ITL and Oncascan Developing Instrument for New Cancer Test
Thursday, June 18, 2015
Integrated Technologies Limited has signed a development contract with
diagnostics start-up Oncascan Limited for a new cancer test.
Applied Biosystems New TaqMan Advanced miRNA Assays
Wednesday, June 17, 2015
These new miRNA assays provide universal reverse transcription designed for superior sensitivity in miRNA analysis by real-time PCR.
Merck Millipore Expands Provantage® Biodevelopment Services with Addition of Provantage® Clone Generation Service
Tuesday, June 16, 2015
Services accelerate time to the clinic by delivering high quality, high expressing cell lines.
Showing Results 21 - 30 of 723
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Specific Variations in RNA Splicing Linked to Breast Cancer
Researchers have identified cellular changes that may play a role in converting normal breast cells into tumors. Targeting these changes could potentially lead to therapies for some forms of breast cancer.
Gene Expression: A Snapshot of Stem Cell Development
New genes found that regulate development of stem cells.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
Editing Genes to Create HIV Killers
Seattle scientists have managed to genetically transform human cells in the lab from HIV targets to HIV killers, and the technique could have implications for cancer and other diseases.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
A New Single-Molecule Tool to Observe Enzymes at Work
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,600+ scientific and medical posters
3,800+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!